Abstract
A clinical epidemiological study must address a research question, which can be explanatory or descriptive and which can be categorized as etiological, diagnostic, or prognostic. The main outcome measures of cancer epidemiology studies are prevalence, incidence, mortality, time to event, and quality of life. Surrogate endpoints are sometimes used instead of clinical endpoints but are controversial. There are many measures of association, which include relative risk, hazard ratio, odds ratio, differences in risk, and differences in mean score. The precision of estimates is described by p values and confidence intervals. Inaccuracies can be caused by various forms of bias, such as confounding, selection bias, and information bias. There are several research designs, which include case series, cross-sectional studies, cohort studies, randomized controlled trials, case-control studies, pilot studies, and systematic reviews.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sackett DL. Clinical epidemiology. What, who, and whither. J Clin Epidemiol. 2002;55:1161–6.
Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users’ guides to the medical literature: XXV. Evidence-based medicine: principles for applying the users’ guides to patient care. Evidence-based medicine working group. JAMA. 2000;284:1290–6.
Moll AC, Imhof SM, Cruysberg JR, et al. Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet. 2003;361:309–10.
Singh AD, De Potter P, Fijal BA, et al. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology. 1998;105:195–8.
Moll AC, Imhof SM, Bouter LM, et al. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945–1994. Int J Cancer. 1996;67:515–9.
U.S. Department of Health and Human Services. Centers for Disease Control and Prevention (CDC). Principles of epidemiology in public health practice: an introduction to applied epidemiology and biostatistics. Atlanta, GA: Office of Workforce and Career Development; 2006.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.
Cohn JN. Introduction to surrogate markers. Circulation. 2004;109(25):IV–20-IV-21.
Foss AJ, Lamping DL, Schroter S, et al. Development and validation of a patient based measure of outcome in ocular melanoma. Br J Ophthalmol. 2000;84:347–51.
Moll AC, Imhof SM, Kuik DJ, et al. High parental age is associated with sporadic hereditary retinoblastoma: the Dutch retinoblastoma register 1862–1994. Hum Genet. 1996;98:109–12.
Fletcher O, Easton D, Anderson K, et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004;96:357–63.
Moll AC, Imhof SM, Schouten-van Meeteren AYN, et al. Screening for pineoblastoma in patients with retinoblastoma. Arch Ophthalmol. 2001;120:1774.
Harbour JW. What is the best treatment for retinoblastoma? Am J Ophthalmol. 2004;138:471–3.
Harbour JW, Brantley MA Jr, Hollingsworth H, et al. Association between choroidal pigmentation and posterior uveal melanoma in a white population. Br J Ophthalmol. 2004;88:39–43.
Abel U, Koch A. The role of randomization in clinical studies: myths and beliefs. J Clin Epidemiol. 1999;52:487–97.
Oxman AD, Guyatt GH. A consumer’s guide to subgroup analyses. Ann Intern Med. 1992;116:78–84.
Lasky T, Stolley PD. Selection of cases and controls. Epidemiol Rev. 1994;16:6–17.
Friedman LM, Furberg CD, De Mets DL. Fundamentals of clinical trials. St. Louis: Mosby; 1996.
Seregard S. Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients. Acta Ophthalmol Scand. 1999;77:414–7.
Further Readings
Bouter LM, Zielhuis GA, Zeegers MP. Textbook of epidemiology. Houten: Bohn Stafleu van Loghum; 2018.
Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: the essentials. Baltimore: Williams & Wilkins; 1996.
Guyatt G, Rennie D, editors. Users’ guide to the medical literature: a manual for evidence-based clinical practice. Chicago: AMA Press; 2002.
Rothman KJ. Epidemiology: an introduction. New York: Oxford University Press; 2002.
Sackett DL, Strauss SE, Richardson WS, et al. Evidence-based medicine. Edinburgh: Churchill Livingstone; 2000.
User’s guide to evidence-based practice. Educative series of articles from the JAMA. www.cche.net/usersguides/main.asp.
Website of the centre for evidence-based medicine, Oxford, United Kingdom. www.cebm.net.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Moll, A.C., de Boer, M.R., Bouter, L.M., Singh, N. (2019). Principles of Cancer Epidemiology. In: Singh, A., Damato, B. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-04489-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-04489-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-04488-6
Online ISBN: 978-3-030-04489-3
eBook Packages: MedicineMedicine (R0)